Affinia Therapeutics
Biotechnology Research
43 Foundry
57 employees
- Employees
- 57
- Contacts
- 3
- Emails
- 3
- Phones
- 3
Affinia Therapeutics Overview
- Headquarters
- 43 Foundry
- Phone Number
- Available in AeroLeads
- Website
- affiniatx.com
- Industry
- Biotechnology Research
- Employees
- 57
- Founded
- 2019
- Funding
- 110.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Affinia Therapeutics
We are a team with decades of proven success in translating science from bench to bedside across many companies and medicines, in gene therapy and beyond. We are driven by a purpose: to make a lasting positive impact in the lives of people affected by devastating rare and prevalent diseases where the genetic cause is understood. Our thesis is simple and our vision, clear: gene therapies have an immense potential to cure many diseases with a one-time dose, but they are limited by current delivery methods for the genetic payload. We formed Affinia Therapeutics to singularly focus on creating innovations that can expand the reach of gene therapies to more prevalent diseases. We're re-engineering adeno-associated virus serotype 9 (AAV9), a gene therapy delivery method that has shown promise but only in a small number of diseases. Our initial focus is on diseases of the heart and the nervous system, where we foresee a generational change in the treatment paradigm similar to what has happened in the treatment of cancers. This is because advances in science are identifying new genes associated with diseases of the heart and the nervous system, making a compelling case for genetic medicines. The heart and nervous system are also tissues where targeted delivery of the therapeutic genetic payload is currently inadequate. Our ART platform gives us an advantage to develop first-in-class or best-in-class product candidates. As an early team member you will play a key role in setting our culture and values. You will be working alongside the founding management team who have a track record of success in the industry. The pace of work is dynamic, fast and fun. Our site includes: State of the Art lab space & Equipment- Healthy Cafe, Outdoor Patio, State of the Art Gym/Yoga Studio, Lounge ( Pool Table/ Golf Simulator ), Free/Plentiful Parking and More! Join Us!
Affinia Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 3
- 75.0% coverage
Affinia Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Michael Ma | Project Portfolio Management - R&D | Greater Boston, United States |
Email
Phone
|
| Rob Aboud | Co-founder and Chief Legal Officer | Waltham, Massachusetts, United States |
Email
Phone
|
| Roger Kitterman | Managing Partner, Mass General Brigham | Brookline, Massachusetts, United States |
Email
Phone
|
| Theresa Donegan M.s. | Quality Assurance and Compliance Expert |
View
|
Employees by Management Level
Individual contributor
5 profiles
Senior / Lead
3 profiles
Associate / junior
3 profiles
Executive
2 profiles
Director
2 profiles
VP / Head
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 4 | 4 | 2 |
| Executive | 1 | 1 | 1 |
| Legal | 1 | 1 | 0 |
Affinia Therapeutics Tech Stack
Data / AI
4 profiles
Compare Similar Companies to Affinia Therapeutics
Vertex Pharmaceuticals
Biotechnology Research
Alexion Pharmaceuticals, Inc.
Biotechnology Research
Beam Therapeutics
Biotechnology Research
Intellia Therapeutics, Inc.
Biotechnology Research
Forge Biologics
Biotechnology Research
Tessera Therapeutics
Biotechnology Research
Voyager Therapeutics, Inc.
Biotechnology Research
Solid Biosciences
Biotechnology Research
Dyno Therapeutics
Biotechnology Research
Tevard Biosciences
Biotechnology